Cargando…
CD133 in Breast Cancer Cells: More than a Stem Cell Marker
Initially correlated with hematopoietic precursors, the surface expression of CD133 was also found in epithelial and nonepithelial cells from adult tissues in which it has been associated with a number of biological events. CD133 is expressed in solid tumors as well, including breast cancer, in whic...
Autores principales: | Brugnoli, Federica, Grassilli, Silvia, Al-Qassab, Yasamin, Capitani, Silvano, Bertagnolo, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766124/ https://www.ncbi.nlm.nih.gov/pubmed/31636668 http://dx.doi.org/10.1155/2019/7512632 |
Ejemplares similares
-
Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133(+)/EpCAM(+) phenotype: a promising target for preventing progression of TNBC
por: Brugnoli, Federica, et al.
Publicado: (2017) -
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells
por: Al-Qassab, Yasamin, et al.
Publicado: (2018) -
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013) -
Ectopic expression of PLC‐β2 in non‐invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR‐146a
por: Bertagnolo, Valeria, et al.
Publicado: (2019) -
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA)
por: Brugnoli, Federica, et al.
Publicado: (2020)